Serum levels of angiogenic factors indicate a pro-angiogenic state in adults with sickle cell disease

British Journal of Haematology

Volumn 134, Issue 1, 2006, Pages 116-119

  Duits, Ashley J ^a   Rodriguez, Tati ^a   Schnog, John John B ^a,b  

^a Red Cross Blood Bank Foundation   (Netherlands Antilles)

^b Slotervaartziekenhuis ^*  (Netherlands)

Author keywords

Angiogenesis; Angiopoietins; Sickle cell disease; Tunica intima endothelial kinase 2; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ERYTHROPOIETIN; HEMOGLOBIN S; INTERCELLULAR ADHESION MOLECULE 1; PLACENTAL GROWTH FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; HEMOGLOBIN SC DISEASE; HUMAN; HYPOXIA; ISCHEMIA; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ACUTE DISEASE; ANEMIA, SICKLE CELL; ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CASE-CONTROL STUDIES; ERYTHROPOIETIN; FETAL HEMOGLOBIN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE COUNT; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; RECEPTOR, TIE-2; STATISTICS, NONPARAMETRIC; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33744790949     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06103.x     Document Type: Article

References (12)

1. Duits A.J. Schnog J.B. Lard L.R. Saleh A.W. Rojer R.A. 1998 Elevated IL-8 levels during sickle cell crisis. European Journal of Haematology, 61, 302 305.
2. Fam N.P. Verma S. Kutryk M. Stewart D.J. 2003 Clinician guide to angiogenesis. Circulation, 108, 2613 2618.
3. Fiedler U. Scharpfenecker M. Koidl S. Hegen A. Grunow V. Schmidt J.M. Kriz W. Thurston G. Augustin H.G. 2004 The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood, 103, 4150 4156.
4. Gunsilius E. Gastl G. 1999 Platelets and VEGF blood levels in cancer patients. British Journal of Cancer, 81, 185 186.
5. Gurkan E. Tanriverdi K. Baslamisli F. 2005 Clinical relevance of vascular endothelial growth factor levels in sickle cell disease. Annals of Hematology, 84, 71 75.
6. Mohan J.S. Lip P.L. Blann A.D. Bareford D. Lip G.Y. 2005 The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. British Journal of Ophthalmology, 89, 815 819.
7. Oh H. Takagi H. Suzuma K. Otani A. Matsumura M. Honda Y. 1999 Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. Journal of Biological Chemistry, 274, 15732 15739.
8. Perelman N. Selvaraj S.K. Batra S. Luck L.R. Erdreich-Epstein A. Coates T.D. Kalra V.K. Malik P. 2003 Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood, 102, 1506 1514.
9. Solovey A. Gui L. Ramakrishnan S. Steinberg M.H. Hebbel R.P. 1999 Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood, 93, 3824 3830.
10. Stuart M.J. Nagel R.L. 2004 Sickle-cell disease. Lancet, 364, 1343 1360.
11. Tarnow L. Astrup A.S. Parving H.H. 2005 Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Scandinavian Journal of Clinical and Laboratory Investigation. Supplement, 240, 73 79.
12. Zhang L. Yang N. Park J.W. Katsaros D. Fracchioli S. Cao G. O'Brien-Jenkins A. Randall T.C. Rubin S.C. Coukos G. 2003 Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Research, 63, 3403 3412.